QuiaPEG

Newsroom

Dec 11, 2018

QuiaPEG Pharmaceuticals Holding AB (publ) today announces that one of the five largest global pharmaceutical companies will place an initial order for activated PEGs (reagents) based on the Uni-Qleaver® platform.

Download press release (PDF)
Contact
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 54 Uppsala
Sweden
+46 (0) 70 693 12 53
info@quiapeg.com

User terms & privacy policy
Send a message